Understanding Decisions Regarding Multiple Myeloma Maintenance Therapy
If you are looking for information about Decisions Regarding Multiple Myeloma Maintenance Therapy, you have come to the right place. Aurora Torres talks with her hematologist-oncologist, C. Ola Landgren, MD,
Key Takeaways about Decisions Regarding Multiple Myeloma Maintenance Therapy
- Panelists Keith Stewart, MB, CHB; Paul Richardson, MD; Sagar Lonial, MD; Saad Usmani, MD; and Amrita Krishnan, MD, discuss ...
- A panel of experts in
- In this week's #AskDrDurie,
- Thomas G. Martin, MD, and Gareth Morgan, MD, PhD, define the value of
- Link to Full Transcript: http://bit.ly/3USTsDg
Detailed Analysis of Decisions Regarding Multiple Myeloma Maintenance Therapy
Noopur Suresh Raje, MD; Heather J. Landau, MD; Rafael Fonseca, MD; Jatin J. Shah, MD, and Morie A. Gertz, MD, examine ... Luciano Costa, MD, PhD, UAB School of Medicine, Birmingham, AL, discusses the use of measurable residual disease (MRD) as ... Gareth Morgan, MD, PhD, FRCP, FRCPath, NYU Langone, New York City, NY, discusses the importance of determining the ...
Keith Stewart, MB, ChB; Gareth Morgan, MD, PhD; Thomas G. Martin, MD; Sagar Lonial, MD; Ivan M. Borrello, MD; and Saad Z.
We hope this detailed breakdown of Decisions Regarding Multiple Myeloma Maintenance Therapy was helpful.
